Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects

Diabetes Technology and Therapeutics

Volumn 8, Issue 2, 2006, Pages 165-173

  Paty, Breay W ^a,b   Senior, Peter A ^a,b   Lakey, Jonathan R T ^a,b   Shapiro, A M James ^a,b   Ryan, Edmond A ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; DACLIZUMAB; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; LIBERASE; PANCREAS ENZYME; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LOW DRUG DOSE; MALE; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 33744900592     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2006.8.165     Document Type: Article

References (22)

1. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000;343:230-238.
2. Ryan EA, Lakey JR, Paty BW, Imes S, Korbutt GS, Kneteman NM, Bigam D, Rajotte RV, Shapiro AM: Successful islet transplantation: continued insulin reserve provides long term control. Diabetes 2002;51:2148-2157.
3. Barshes NR, Lee T, Goodpasture S, Brunicardi FC, Alejandro R, Ricordi C, Soltes G, Barth M, Hamilton D, Goss JA: Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review. Transplant Proc 2004;36:1127-1129.
4. Markmann JF, Deng S, Huang X, Desai NM, Velidedeoglu E, Lui C, Frank A, Markmann E, Palanjian M, Brayman K, Wolf B, Bell E, Vitamaniuk M, Doliba N, Matschinsky F, Barker C, Naji A: Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 2003;237:741-750.
5. Hering BJ, Kandaswamy R, Ansite JD, Eckman PM, Nakano M, Sawada T, Matsumoto I, Ihm SH, Zhang HJ, Parkey J, Hunter DW, Sutherland DE: Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005;293:830-835.
6. Paty BW, Ryan EA, Lakey JR, Shapiro AM. Islet transplantation. In: LeRoith D, Olefsky JM, Taylor SI, eds. Diabetes Mellitus: A Fundamental and Clinical Text, 3rd ed. Philadelphia: Lippincott, Williams and Wilkins, 2003:721-732.
7. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM: Five-year follow-up after clinical islet transplantation. Diabetes 2005;54:2060-2069.
8. Ryan EA, Shandro T, Green K, Paty BW, Senior PA, Bigam D, Shapiro AM, Vantyghem M: Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetes subjects undergoing islet transplantation. Diabetes 2004;53:955-962.
9. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970;19:644-655.
10. Mastrototaro JJ: The Minimed continuous glucose monitoring system. Diabetes Technol Ther 2000;2(Suppl 1):S13-S18.
11. Linetsky E, Bottino R, Lehmann R, Alejandro R, Inverardi L, Ricordi C: Improved human islet isolation using a new enzyme blend, liberase. Diabetes 1997;46:1120-1123.
12. Lakey JR, Warnock GL, Shapiro AM, Korbutt GS, Ao Z, Kneteman NM, Rajotte RV: Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant 1999;8:285-292.
13. Ricordi C, Gray DW, Hering BJ, Kaufman DB, Warnock GL, Kneteman NM, Lake SP, London NJ, Socci C, Alejandro R: Islet isolation assessment in man and large animals. Acta Diabetol Lat 1990;27:185-195.
14. Owen RJ, Ryan EA, O'Kelly K, Lakey JR, McCarthy MC, Paty BW, Bigam DL, Kneteman NM, Korbutt GS, Rajotte RV, Shapiro AM: Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects. Radiology 2003;229:165-170.
15. Bode BW, Hirsch IB: Using the continuous glucose monitoring system to improve the management of type 1 diabetes. Diabetes Technol Ther 2000;2(Suppl 1):S43-S48.
16. Yogev Y, Ben-Haroush A, Chen R, Kaplan B, Phillip M, Hod M: Continuous glucose monitoring for treatment adjustment in diabetic pregnancies-a pilot study. Diabet Med 2003;20:558-562.
17. Alemzadeh R, Loppnow C, Parton E, Kirby M: Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus. Diabetes Technol Ther 2003;5:167-173.
18. Ludvigsson J, Hanas R: Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 2003;111:933-938.
19. Kessler L, Passemard R, Oberholzer J, Benhamou PY, Bucher P, Toso C, Meyer P, Penfornis A, Badet L, Wolf P, Colin C, Morel P, Pinget M: Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation: interest of continuous glucose monitoring. Diabetes Care 2002;25:2256-2262.
20. Rickels MR, Schutta MH, Markmann JF, Barker CF, Naji A, Teff KL: Beta-cell function following human islet transplantation for type 1 diabetes. Diabetes 2005;54:100-106.
21. McGowan K, Thomas W, Moran A: Spurious reporting of nocturnal hypoglycemia by CGMS in patients with tightly controlled type 1 diabetes. Diabetes Care 2002;25:1499-1503.
22. Monsod TP, Flanagan DE, Rife F, Saenz R, Caprio S, Sherwin RS, Tamborlane WV: Do sensor glucose levels accurately predict plasma glucose concentrations during hypoglycemia and hyperinsulinemia? Diabetes Care 2002;25:889-893.